Suchergebnisse - "Onoue, Satomi"

PubPharm (18)

1

Respirable powder formulation of a shortened vasoactive intestinal peptide analog for treatment of airway inflammatory diseases

enthalten in: Journal of peptide science : an official publication of the European Peptide Society | 2018

von Suzuki, H. | Mizumoto, T. | Seto, Y. | +2

2

Chemical synthesis and formulation design of a PEGylated vasoactive intestinal peptide derivative with improved metabolic stability

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2013

von Onoue, S. | Matsui, T. | Kato, M. | +6

3

Inhalable sustained-release formulation of long-acting vasoactive intestinal peptide derivative alleviates acute airway inflammation

enthalten in: Peptides | 2012

von Onoue, S. | Matsui, T. | Kuriyama, K. | +6

4

Formulation design and in vivo evaluation of dry powder inhalation system of new vasoactive intestinal peptide derivative ([R(15, 20, 21), L(17), A(24,25), des-N(28)]-VIP-GRR) in experimental asthma/COPD model rats

enthalten in: International journal of pharmaceutics | 2011

von Onoue, S. | Aoki, Y. | Matsui, T. | +4

5

Novel vasoactive intestinal peptide derivatives with improved stability protect rat alveolar L2 cells from cigarette smoke-induced cytotoxicity and apoptosis

enthalten in: Peptides | 2011

von Misaka, S. | Sato, H. | Aoki, Y. | +3

6

Inhalable powder formulation of vasoactive intestinal peptide derivative, [R15,20,21, L17]-VIP-GRR, attenuated neutrophilic airway inflammation in cigarette smoke-exposed rats

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2010

von Onoue, S. | Misaka, S. | Aoki, Y. | +5

7

Inhalable powder formulation of a stabilized vasoactive intestinal peptide (VIP) derivative : anti-inflammatory effect in experimental asthmatic rats

enthalten in: Peptides | 2010

von Misaka, S. | Aoki, Y. | Karaki, S. | +4

8

Physicochemical and pharmacological characterization of novel vasoactive intestinal peptide derivatives with improved stability

enthalten in: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V | 2009

von Onoue, S. | Misaka, S. | Ohmori, Y. | +6

9

Structure-activity relationship of vasoactive intestinal peptide (VIP) : potent agonists and potential clinical applications

enthalten in: Naunyn-Schmiedeberg's archives of pharmacology | 2008

von Onoue, S. | Misaka, S. | Yamada, S.

10

Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP) for the treatment of asthma/COPD

enthalten in: Peptides | 2007

von Onoue, S. | Yamada, S. | Yajima, T.